Veno's Cough Syrup: Indications, Dosage, Precautions, Adverse Effects
  • Россия
  • Украина

Veno's Cough Syrup - Product Information

Manufacture: Forest Laboratories, Inc.
Country: United States
Condition: Respiratory Tract Infection, Upper (Upper Respiratory Tract Infection)
Class: Glucose elevating agents
Form: Syrup
Ingredients: Glucose Liquid 3.18 g, Treacle 1.35 g, Capsicum tincture, aniseed oil, xanthan gum, camphor racemic, glacial acetic acid, sodium benzoate (E211), sodium metabisulphite (E 223), levomenthol, water and colour caramel (E 150).

Name of the Medicinal Product

Veno's Cough Syrup

Qualitative and Quantitative Composition

Glucose liquid 3.18 g, Treacle 1.35 g

For excipients, see List of Excipients.

Pharmaceutical Form


Clinical Particulars

Therapeutic Indications

Recommended for the symptomatic relief of sore throat and unproductive cough in minor respiratory tract infections.

Posology and Method of Administration

Adults and children over the age of 12

Take one 5 ml or 10 ml dose (one or two 5 ml spoonfuls). Repeat the dose every 2 or 3 hours.

Children aged 3 to under 12 years

Take one 5 ml dose (one 5 ml spoonful) and give every 2 to 3 hours. Do not give to children under 3 years except on medical advice.

Route of Administration



Hypersensitivity to glucose, treacle or any other of the ingredients.

Special Warnings and Precautions for Use

Special Label Warnings

Keep all medicines out of the sight and reach of children.

If symptoms persist consult your doctor.

Total sugars content 3.6 g per 5 ml.

Interaction With Other Medicinal Products and Other Forms of Interaction


Fertility, Pregnancy and Lactation

Use in pregnancy and lactation is not contraindicated. However, as with all medicines, caution should be exercised during pregnancy and lactation.

Effects on Ability to Drive and Use Machines


Undesirable Effects

Immune system disorders

Hypersensitivity reactions e.g. skin rash.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at:


The product does not contain any ingredient in a high enough concentration to cause toxic effects; therefore no specific symptoms of overdosage would be anticipated and no antidotes would be required.

Pharmacological Properties

Pharmacodynamic Properties

Treacle and glucose liquid are demulcents, which will help relieve an unproductive cough and will soothe a sore throat.

Pharmacokinetic Properties

None Stated.

Preclinical Safety Data

There are no preclinical data of any relevance additional to that already included in other sections of the SmPC.

Pharmaceutical Particulars

List of Excipients

Capsicum tincture, aniseed oil, xanthan gum, camphor racemic, glacial acetic acid, sodium benzoate, sodium metabisulphite (E223), levomenthol, water and colour caramel (E150).



Shelf Life

Unopened: Three years

Opened: Six months

Special Precautions for Storage


Nature and Contents of Container

Clear glass bottle with a roll-on, pilfer proof, aluminium cap containing a melinex-coated aluminium-faced pulp-board wad. The bottle is contained in a boxboard carton.

Pack sizes: 100 ml, 160 ml.

Not all pack sizes may be marketed.

Special Precautions for Disposal and Other Handling


Marketing Authorisation Holder

Forest Laboratories UK Limited,
Whiddon Valley,
North Devon,
EX32 8NS,
United Kingdom.

Marketing Authorisation Number(s)

PL 00108/0339

Date of First Authorisation/Renewal of the Authorisation

28 September 1988 / 15 February 2005

Date of Revision of the Text


Company Contact Details

Forest Laboratories UK Limited (a subsidiary of Actavis PLC) 

Whiddon Valley, Barnstaple, Devon, EX32 8NS, UK

+44 (0)1271 311 200

+44 (0)1271 346106

Medical Information Direct Line
+44(0)1271 385 257

Medical Information e-mail